跳至主要内容
临床试验/ISRCTN34918844
ISRCTN34918844已完成不适用

Intravenous metoclopramide versus intravenous promethazine for hyperemesis gravidarum: a double-blind, randomised trial

niversity of Malaya (Malaysia)0 个研究点目标入组 128 人开始时间: 2008年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant women, age limit >17 to 50 years
  • 2. Gestation <16 weeks
  • 3. First hospitalisation for hyperemesis gravidarum in current pregnancy
  • 4. Clinical dehydration with ketonuria on urine dipstick

排除标准

  • 1. Multiple gestation
  • 2. Established non viable pregnancy
  • 3. Allergy to metoclopramide or promethazine
  • 4. Pre-exiting medical condition which can cause nausea and vomiting if known, for example:
  • 4.1. Concomitant confounders of severity of nausea and vomiting e.g. culture proven symptomatic urinary tract infection, dengue fever
  • 4.2. Gastrointestinal causes of vomiting e.g. gastro-enteritis
  • 4.3. Medical causes of vomiting e.g. diabetic ketoacidosis

研究者

发起方
niversity of Malaya (Malaysia)

相似试验